Tag: INFI

  • Early Morning Vibes: 4 Top Trending Stocks To Watch Right Now

    On February 4, American stock indices closed in the green. The S&P 500 Index climbed 1.09% to 3872 points, reaching a new all-time high. Dow Jones rose 1.08%, NASDAQ – 1.23%. The news background remained mostly calm. High investor risk appetite may be associated with positive macroeconomic statistics. The finance sector was the top gainer, rallying 2.27% on the back of a rally in payments stocks following a PayPal report. The tech sector added 1.55% on positive performance in Apple shares.

    Company news

    PayPal (PYPL: + 7.4%) successfully reported for the fourth quarter amid a boom in online trading and an increase in cryptocurrency transactions.

    Qualcomm’s revenue (QCOM: -8.8%) was in line with expectations, which did not allow the company to distinguish itself from the unexpectedly strong results of competitors.

    EBay (EBAY: + 5.3%) results beat consensus due to explosive growth in eCommerce during the reporting period.

    Today, global stock exchanges are showing positive dynamics. The optimism remains mainly related to the prospects for the adoption of the fiscal stimulus package. President Biden said yesterday that he was not ready to reduce the volume of direct payments to the population and insisted that they remain at $ 1400. Nevertheless, the head of the White House will probably consider the idea of ​​limiting the circle of citizens who are entitled to subsidies. This item of the program is of increased interest due to the extremely high activity of private investors, which caused a wave of short squeezes last week. It is expected that part of the funds received from the state will be invested by the population in the stock market but estimates of the potential inflow of liquidity are still very different.

    The focus of attention of market participants today will be focused on makrostatistiki. Strong data on the labor market is expected, which may serve as a fresh driver for the continuation of the upward movement. The companies’ quarterly reports continue to support risk appetite, with a positive initial investor reaction to the reports prevailing.

    Sentiment Index

    The Freedom Finance Sentiment Index remains at 68 out of 100. The index reflects market participants’ hope for a global economic recovery in 2021. Concerns about the negative impact of the coronavirus pandemic are gradually diminishing thanks to the prospect of mass vaccinations.

    Technical picture

    Technically, the S&P 500 is still in a medium-term uptrend. The day before, the broad market index reached a new high, which signals the continued activity of buyers. The short-term outlook will depend on whether the bulls can hold the S&P 500 above 3870 points. The next resistance is at 3900 points, where the upper trend line lies.

    Today Top Movers‎T2 Biosystms Inc (TTOO), a healthcare firm, soared about 47.50% ‎at $3.54 in pre-market ‎trading Friday following the news of efficiency of its T2SARS-CoV-2™ Panel to ‎detect Brazil (P.1) variant of the SARS-CoV-2 virus.‎ ‎

    Aurora Mobile Ltd (JG) share price jumped 112.31% to $8.45 during the early morning ‎trading session on ‎Friday after declaring a partnership agreement with Kuaishou Technology, to improve advertising monetization efficiency. ‎ Supercom Lt (SPCB) stock ascended 37.85% at $1.93 in the pre-market trading today.‎ The company recently revealed the closing of financing with gross proceeds of $7 million to support the company’s growth capital needs. ‎LAIX Inc (LAIX) gained over 172.66% at $6.98 in pre-market ‎trading on Friday.‎ It appears there was a coordinated move on social media to drive the price up.

    Top Upgrades & Downgrades

    BTIG turned bullish on Canada Goose Holdings Inc. (GOOS), upgrading the stock to “Neutral”

    Infinity Pharmaceuticals Inc. (INFI) has won the favor of JPMorgan’s equity research team. The firm upgraded the shares from Underweight to Neutral

    CMS Energy Corporation (CMS) received an upgrade from analysts at Credit Suisse, who also set their one-year price target on the stock to $64. They changed their rating on CMS to Outperform from Neutral in a recently issued research note. 

    Earlier Friday Oppenheimer reduced its rating on New Relic Inc. (NEWR) stock to Perform from Outperform. 

    Wells Fargo analysts reduced their investment ratings, saying in research reports covered by the media that its rating for Bruker Corporation (BRKR) has been changed to Equal Weight from Overweight and the new price target is set at $55. 

    Analysts at Raymond James downgraded Peloton Interactive Inc. (PTON)’s stock to Market Perform from Outperform Friday.

    Latest Insider Activity

    Palantir Technologies Inc. (PLTR) Karp Alexander C. announced the sale of shares taking place on Feb 02 at $31.59 for some 1,285,123 shares. The total came to more than $40.6 million. 

    Delta Air Lines Inc. (DAL) Int Co-CFO & SVP, Fin & Cntlr Carroll William C sold on Feb 02 a total of 19,481 shares at $38.55 on average. The insider’s sale generated proceeds of almost $0.1 million. 

    The Charles Schwab Corporation (SCHW) Director Ruffel Charles A. declared the purchase of shares taking place on Feb 04 at $54.08 for some 3,636 shares. The transaction amount was around $0.2 million. 

    Aurinia Pharmaceuticals Inc. (AUPH) Director Leversage Jill bought on Jan 29 a total 400 shares at $16.03 on average. The purchase cost the insider an estimated $6,412.

    Important Earnings

    Top US earnings releases scheduled for today include GrafTech International Ltd. (NYSE: EAF). It will announce its Dec 2020 financial results. The company is expected to report earnings of $0.4 per share from revenues of $300.16M in the three-month period. 

    Analysts expect Cardinal Health Inc. (NYSE: CAH) to report a net income (adjusted) of $1.44 per share when the bank releases its quarterly results shortly. Revenue for the fiscal quarter ended Dec 2020 is predicted to come in at $41.44B. 

    Sanofi (SNY), due to announce earnings before the market opens today, is expected to report earnings of $0.69 per share from revenues of $11.39B recently concluded three-month period.

  • 15 Trending Stocks in Biotechnology Industry

    15 Trending Stocks in Biotechnology Industry

    This year, biotech companies on the stock exchange have skyrocketed. This is no surprise since biotech firms are the leaders in the battle against the coronavirus pandemic. Even with Pfizer’s first vaccine in the UK, investors and pharmaceutical companies are well aware that the race is far ahead.
    Other diseases should not be ignored apart from coronavirus vaccines. The biotech sector is also creating headlines and innovating in areas linked to dementia, cancer, hereditary disorders, etc. Given the above, buyers are probably faced with the difficulty of choosing the best ones to purchase.

    Curis Inc. (NASDAQ:CRIS) shares were trading up 354.86% at $6.55 at the time of writing on Tuesday following announcement of proposed public offering of common stock.

    Curis Inc. (NASDAQ:CRIS) share price went from a low point around $0.62 to briefly over $3.59 in past 52 weeks, though shares have since pulled back to $6.55. CRIS market cap has remained high, hitting $409.70M at the time of writing, giving it price-to-sales ratio of more than 30.

    If we look at the recent analyst rating CRIS, Laidlaw initiated coverage on CRISshares with a Buy rating.

    Lexicon Pharmaceuticals Inc. (LXRX) last closed at $3.08, in a 52-week range of $1.03 to $5.33. Analysts have a consensus price target of $2.37. On November 17, 2020, the firmreported that both the SOLOIST and SCORED Phase 3 studies achieved their primary endpoints by demonstrating statistically significant reductions in total cardiovascular deaths, hospitalizations for heart failure and urgent heart failure visits in patients treated with sotagliflozin as compared with placebo.

    IGM Biosciences Inc. (IGMS) stock soar by 57.75% to $115.03 after declaringpricing of upsized $200 million public offering. The most recent rating by Robert W. Baird, on July 17, 2020, is at an Outperform.

    Infinity Pharmaceuticals Inc. (NASDAQ:INFI) Shares headed rising, higher as much as 29.44%. The company will hold a conference call on Wednesday, December 9, 2020 at 10:00 a.m. ET to discuss clinical data from ongoing studies evaluating eganelisib in triple negative breast cancer (TNBC) The most recent rating by Oppenheimer, on June 27, 2019, is at an Outperform.

    Oncternal Therapeutics Inc. (NASDAQ:ONCT) rose 27.64% after gaining more than $1.1 on Tuesday after reporting updated interim clinical data from the ongoing Phase 1/2 CIRLL (Cirmtuzumab and Ibrutinib targeting ROR1 for Leukemia and Lymphoma) clinical trial.

    Proteostasis Therapeutics Inc. (PTI) last closed at $1.23, in a 52-week range of $0.87 to $4.72. The firm reported on November 16, 2020. a net loss of approximately $8.2 million for the three months ended September 30, 2020, as compared to a net loss of $12.8 million for the same period in the prior year.

    InflaRx N.V. (IFRX) stock soar by 18.27% to $4.79. The most recent rating by SVB Leerink, on November 06, 2020, is at an Outperform.

    Syros Pharmaceuticals Inc. (NASDAQ:SYRS) Shares headed rising, higher as much as 17.47% after closing $90.5 million strategic financing. The most recent rating by H.C. Wainwright, on November 04, 2020, is at a Buy.

    Aerpio Pharmaceuticals Inc. (NASDAQ:ARPO) rose 16.28% after gaining more than $0.28 on Tuesday.

    Ampio Pharmaceuticals Inc. (AMPE) last closed at $1.35, in a 52-week range of $0.31 to $1.39. The firm recently revealed that it will conduct its annual meeting in a virtual format only on December 12, 2020 at 9:00 am MST.

    Regulus Therapeutics Inc. (RGLS)stock soar by 15.19% to $0.93 following the closing of $19.4 million private placement of equity. The most recent rating by B. Riley FBR Inc., on March 28, 2018, is at a Neutral.

    Cancer Genetics Inc. (NASDAQ:CGIX) Shares headed rising, higher as much as 14.79%. The most recent rating by Maxim Group, on December 07, 2017, is at a Buy.

    Marinus Pharmaceuticals Inc. (NASDAQ:MRNS) fall -11.85% after losing more than -$1.85 on Tuesday. The healthcare firm lately declared pricing of $70 million public offering of common stock, which is expected to close on or about December 10, 2020.

    iBio Inc. (IBIO) last closed at $1.31, in a 52-week range of $0.19 to $7.45 after declaring pricing of $35 million public offering of common stock. Analysts have a consensus price target of $2.00.

    Vaccinex Inc. (VCNX) stock soar by 14.08% to $2.35. The most recent rating by BTIG Research, on September 23, 2020, is at a Neutral.